Ikarian Capital’s Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda) CYTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-188
| Closed | -$36K | – | 133 |
|
|
2022
Q2 | $36K | Sell |
188
-612
| -77% | -$117K | 0.01% | 96 |
|
|
2022
Q1 | $351K | Buy |
800
+38
| +5% | +$16.7K | 0.05% | 111 |
|
|
2021
Q4 | $553K | Sell |
762
-236
| -24% | -$171K | 0.08% | 94 |
|
|
2021
Q3 | $803K | Sell |
998
-13
| -1% | -$10.5K | 0.06% | 102 |
|
|
2021
Q2 | $1.45M | Sell |
1,011
-143
| -12% | -$204K | 0.12% | 100 |
|
|
2021
Q1 | $1.61M | Buy |
+1,154
| New | +$1.61M | 0.05% | 112 |
|